Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor
- 1 March 2001
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 31 (2-3) , 193-202
- https://doi.org/10.1016/s0169-5002(00)00184-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Reduced expression of syndecan‐1 in human hepatocellular carcinoma with high metastatic potentialInternational Journal of Cancer, 1997
- Heparan sulfate proteoglycan expression in human lung-cancer cellsInternational Journal of Cancer, 1997
- The Role of Syndecan-1 in MalignanciesAnnals of Medicine, 1996
- Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.Proceedings of the National Academy of Sciences, 1994
- Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancerCancer, 1991
- Proteoglycans as modulators of growth factor activitiesCell, 1991
- Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancerCancer, 1990
- Expression of epidermal growth factor receptors in four histologic cell types of lung cancerJournal of Surgical Oncology, 1989
- Expression of epidermal growth factor receptors in human lung tumorsCancer, 1986
- A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.Proceedings of the National Academy of Sciences, 1985